Narrow search
Showing 1 - 10 of 2,438
Cover Image
Technological Sovereignty as Ability, Not Autarky
March, Christoph; Schieferdecker, Ina - 2021
globalization. We develop a competence-based definition of technological sovereignty, which puts innovation policy at the core of … cooperation and trade. Two case studies illustrate how innovation policy might be used to achieve technological sovereignty …
Persistent link: https://www.econbiz.de/10013222214
Cover Image
Spite in Litigation
Mill, Wladislaw; Stäbler, Jonathan - 2023
This paper studies how litigation and settlement behavior is affected by agents motivated by spiteful preferences under the American and the English fee-shifting rule. We conduct an experiment and find that litigation expenditures and settlement requests are higher for more spiteful...
Persistent link: https://www.econbiz.de/10014260383
Cover Image
Efficient Level of Seps Licensing
Langus, Gregor; Lipatov, Vilen - 2022
We study the question whether a holder of standard essential patents (SEPs) should be allowed to choose the level in the value chain at which to offer a FRAND license to its SEPs. We give a pos-itive answer to this question for two reasons. First, the SEP holder and the social planner tend to...
Persistent link: https://www.econbiz.de/10013300871
Cover Image
The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value
Songane, Mario - 2020
HPV vaccination rates while keeping innovation incentives. We estimate the global patent buyout price as the present … to fight the disease. However, high vaccine prices enforced through patent protection are limiting vaccine expansion …, particularly in low- and middle-income countries. By limiting market power, patent buyouts could reduce vaccine prices and raise …
Persistent link: https://www.econbiz.de/10012825394
Cover Image
Science vs. Profit in Research. Lessons from the Human Genome Project
Carraro, Carlo; Pomè, Alessandra; Siniscalco, Domenico - 2001
This paper elaborates on the recent race to sequence the human genome. Starting from the debate on public vs. private research arising from the genome case, the paper shows that in some fundamental research areas, where knowledge externalities play an important role, market and non-market...
Persistent link: https://www.econbiz.de/10010315164
Cover Image
Heterogeneous Merger Impacts on Competitive Outcomes
Siebert, Ralph - 2017
Mergers realize heterogeneous competitive effects on profits, production, and prices. To date, it is unclear whether differential merger outcomes are caused mostly by firms’ technology or product market attributes. Furthermore, empirical merger studies conventionally assume that, conditional...
Persistent link: https://www.econbiz.de/10011744913
Cover Image
Dynamic Mergers Effects on R&D Investments and Drug Development across Research Phases in the Pharmaceutical Industry
Siebert, Ralph; Tian, Zhili - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms’ internal drug development capability. We evaluate the effects of M&As on firms’ post-merger R&D...
Persistent link: https://www.econbiz.de/10012227643
Cover Image
Technological Sovereignty as Ability, Not Autarky
March, Christoph; Schieferdecker, Ina - 2021
globalization. We develop a competence-based definition of technological sovereignty, which puts innovation policy at the core of … cooperation and trade. Two case studies illustrate how innovation policy might be used to achieve technological sovereignty. …
Persistent link: https://www.econbiz.de/10012599226
Cover Image
The Impact of Horizontal Mergers on Market Structure: Evidence from the Semiconductor Industry
Siebert, Ralph - 2016
-level information on mergers, production, and innovation in the dynamic random access memory semiconductor market from 1985 to 2004. Our …
Persistent link: https://www.econbiz.de/10011522411
Cover Image
Dynamic Mergers Effects on R&D Investments and Drug Development Across Research Phases in the Pharmaceutical Industry
Siebert, Ralph - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D investments...
Persistent link: https://www.econbiz.de/10012833741